Evidence map›Paper›PMID 31687335›Full record

ArticleMolecular genetics and metabolism reports2019

Transition of patients with mucopolysaccharidosis from paediatric to adult care.

C Lampe, B McNelly, A K Gevorkian, C J Hendriksz, T V Lobzhanidze, J Pérez-López, K M Stepien, N D Vashakmadze, M Del Toro

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics and metabolism reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Unmet Cardiac Clinical Needs in Adult Mucopolysaccharidoses.Frontiers in cardiovascular medicine · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

C LampeHELIOS Dr. Horst Schmidt Kliniken, Wiesbaden, Germany.
B McNellySalford Royal NHS Foundation Trust, Salford, United Kingdom.
A K GevorkianResearch Center for Children's Health, Moscow, Russia.
C J HendrikszUniversity of Pretoria, Pretoria, South Africa.
T V LobzhanidzeResearch Center for Children's Health, Moscow, Russia.
J Pérez-LópezVall d'Hebron University Hospital, Barcelona, Spain.
K M StepienSalford Royal NHS Foundation Trust, Salford, United Kingdom.
N D VashakmadzeResearch Center for Children's Health, Moscow, Russia.
M Del ToroVall d'Hebron University Hospital, Barcelona, Spain.
Scientific Center of Children's Health · RUSalford Royal NHS Foundation Trust · GBVall d'Hebron Hospital Universitari · ESHelios Dr. Horst Schmidt Kliniken Wiesbaden · DEUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucopolysaccharidoses (MPS) are rare disorders associated with enzyme deficiencies, resulting in glycosaminoglycan (GAG) accumulation in multiple organ systems. As patients increasingly survive to adulthood, the need for a smooth transition into adult care is essential. Using case studies, we outline strategies and highlight the challenges of transition, illustrating practical solutions that may be used to optimise the transition process for patients with MPS disorders. Seven MPS case studies were provided by four European inherited metabolic disease centres; six of these patients transferred to an adult care setting and the final patient remained under paediatric care. Of the patients who transferred, age at the start of transition ranged between 14 and 18 years (age at transfer ranged from 16 to 19 years). While there were some shared features of transition strategies, they varied in duration, the healthcare professionals involved and the management of adult patients with MPS. Challenges included complex symptoms, patients' unwillingness to attend appointments with unfamiliar team members and attachment to paediatricians. Challenges were resolved by starting transition at an early age, educating patients and families, and providing regular communication with and reassurance to the patient and family. Sufficient time should be provided to allow patients to understand their responsibilities in the adult care setting while feeling assured of continued support from healthcare professionals. The involvement of a coordinated multidisciplinary team with expertise in MPS is also key. Overall, transition strategies must be comprehensive and individualised to patients' needs.

Indexed as

Case studiesENT, ear nose and throatERT, enzyme replacement therapyGAG, glycosaminoglycanGP, general practitionerHCP, healthcare professionalsMDT, multidisciplinary teamMetabolic diseaseMPS, mucopolysaccharidosisMucopolysaccharidosisMultidisciplinary teamNHS, National Health ServiceNICE, National Institute for Health and Clinical ExcellenceTransition

Identifiers

PMID31687335
PMCPMC6819742
OpenAlexW2982143169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.